Market Closed -
Toronto S.E.
02:13:50 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
1,094
CAD
|
+1.89%
|
|
+1.23%
|
+4.39%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,906
|
3,255
|
2,766
|
3,288
|
3,097
|
3,626
|
Enterprise Value (EV)
1 |
3,062
|
3,416
|
2,941
|
3,254
|
3,497
|
3,919
|
P/E ratio
|
187
x
|
4.83
x
|
6.39
x
|
3.2
x
|
-16.7
x
|
4.27
x
|
Yield
|
0.68%
|
0.6%
|
0.65%
|
0.96%
|
1.12%
|
1.43%
|
Capitalization / Revenue
|
2.7
x
|
1.11
x
|
1.09
x
|
1.32
x
|
-4.78
x
|
1.32
x
|
EV / Revenue
|
2.84
x
|
1.17
x
|
1.16
x
|
1.31
x
|
-5.4
x
|
1.42
x
|
EV / EBITDA
|
25.4
x
|
3.24
x
|
3.94
x
|
2.11
x
|
-11.1
x
|
2.63
x
|
EV / FCF
|
17.7
x
|
5.79
x
|
49.2
x
|
3.47
x
|
-8.28
x
|
4.18
x
|
FCF Yield
|
5.64%
|
17.3%
|
2.03%
|
28.8%
|
-12.1%
|
23.9%
|
Price to Book
|
0.55
x
|
0.54
x
|
0.44
x
|
0.47
x
|
0.48
x
|
0.51
x
|
Nbr of stocks (in thousands)
|
3,927
|
3,927
|
3,616
|
3,615
|
3,464
|
3,460
|
Reference price
2 |
740.0
|
829.0
|
765.0
|
909.5
|
894.0
|
1,048
|
Announcement Date
|
3/7/19
|
3/11/20
|
3/10/21
|
3/10/22
|
3/9/23
|
3/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,077
|
2,930
|
2,536
|
2,482
|
-647.4
|
2,753
|
EBITDA
1 |
120.4
|
1,055
|
746.5
|
1,544
|
-316.1
|
1,489
|
EBIT
1 |
109.8
|
1,044
|
734.3
|
1,529
|
-327
|
1,480
|
Operating Margin
|
10.2%
|
35.62%
|
28.95%
|
61.6%
|
50.52%
|
53.76%
|
Earnings before Tax (EBT)
1 |
89.23
|
1,027
|
713.5
|
1,497
|
-355
|
1,274
|
Net income
1 |
28.05
|
747.9
|
503.7
|
1,166
|
-173.1
|
955.3
|
Net margin
|
2.61%
|
25.52%
|
19.86%
|
46.96%
|
26.73%
|
34.7%
|
EPS
2 |
3.960
|
171.6
|
119.7
|
284.4
|
-53.47
|
245.2
|
Free Cash Flow
1 |
172.8
|
590.3
|
59.8
|
937
|
-422.3
|
937.9
|
FCF margin
|
16.04%
|
20.15%
|
2.36%
|
37.74%
|
65.24%
|
34.07%
|
FCF Conversion (EBITDA)
|
143.54%
|
55.96%
|
8.01%
|
60.7%
|
-
|
62.99%
|
FCF Conversion (Net income)
|
615.89%
|
78.93%
|
11.87%
|
80.37%
|
-
|
98.18%
|
Dividend per Share
2 |
5.000
|
5.000
|
5.000
|
8.750
|
10.00
|
15.00
|
Announcement Date
|
3/7/19
|
3/11/20
|
3/10/21
|
3/10/22
|
3/9/23
|
3/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
156
|
161
|
175
|
-
|
400
|
293
|
Net Cash position
1 |
-
|
-
|
-
|
33.9
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.298
x
|
0.1526
x
|
0.2338
x
|
-
|
-1.265
x
|
0.1965
x
|
Free Cash Flow
1 |
173
|
590
|
59.8
|
937
|
-422
|
938
|
ROE (net income / shareholders' equity)
|
0.87%
|
12.4%
|
8.03%
|
15.8%
|
-4.01%
|
14%
|
ROA (Net income/ Total Assets)
|
0.31%
|
2.89%
|
1.88%
|
3.69%
|
-0.81%
|
3.74%
|
Assets
1 |
8,987
|
25,850
|
26,726
|
31,556
|
21,291
|
25,568
|
Book Value Per Share
2 |
1,339
|
1,532
|
1,720
|
1,944
|
1,851
|
2,036
|
Cash Flow per Share
2 |
84.70
|
77.20
|
118.0
|
176.0
|
87.40
|
131.0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/7/19
|
3/11/20
|
3/10/21
|
3/10/22
|
3/9/23
|
3/8/24
|
|
1st Jan change
|
Capi.
|
---|
| +4.39% | 2.69B | | +14.78% | 79.51B | | +6.49% | 50.22B | | +1.35% | 48.11B | | +6.55% | 39.71B | | +19.34% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -18.42% | 24.71B | | +6.89% | 21.99B |
Other Life & Health Insurance
|